Teaching Gender-Affirming Care: A Case-based Simulation to Improve Transgender Health Outcomes

Friday, December 5, 2025, 12:00 AM - Monday, December 4, 2028, 11:59 PM, On Demand

Experience an immersive, simulation-based training program designed to strengthen clinical skills in caring for transgender and gender-diverse (TGD) patients. Through 18 dynamic clinical encounters spanning eight virtual patient cases, learners make real-time decisions that directly influence patient trust, stress levels, and health outcomes.

Grounded in evidence-based guidelines and shaped by the lived experiences of TGD individuals, this course addresses a critical gap in medical education by offering an accessible, low-cost opportunity to practice gender-affirming communication and care.

Interactive scenarios, structured feedback, and guided reflection support participants in building the empathy, clinical confidence, and practical skills needed to provide equitable, affirming care for TGD patients across a wide range of healthcare settings.

     Release Date: December 05, 2025
     Expiration Date: December 04, 2028
     Estimated Time to Complete: 5 Hours
     Registration Fee: FREE

Click Begin (at the top) to learn more about how to enroll in the course. 

AMA PRA Category 1 Credits™ (5.00 hours), ANCC Contact Hours (5.00 hours), Non-Physician Participation Credit (5.00 hours)

1. Demonstrate inclusive, patient-centered communication strategies that affirm the identities and experiences of transgender and gender-diverse individuals across the lifespan.
2. Apply knowledge of gender-affirming medical therapies—including testosterone and estradiol regimens—to support individualized transition goals while managing associated clinical considerations.
3. Identify ethical, legal, and institutional considerations in the care of transgender and gender-diverse patients, including confidentiality, consent, and documentation practices.
4. Describe the implications of gender-affirming care on reproductive health and fertility, and counsel patients on preservation options and long-term planning.

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Enduring Material for a maximum of 5.00 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Nurses Credentialing Center (ANCC) 
Stanford Medicine designates this Enduring Material activity for a maximum of 5.00 ANCC contact hours.  

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require visual, auditory, cognitive, or mobility accommodations, including dietary concerns, please contact the CME office.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

References/Bibliography
Artime TM, Rosenfeld EA, Ong L, Lisha NE, Dilley JW, Shumway M, Edward D, Ceja A, Einhorn L, Lubensky ME, Dastur Z, Lunn MR, Obedin-Maliver J, Cloitre M, Flentje A. Mental Health Treatment Experiences among Sexual and Gender Minority Individuals: Trauma Exposure, Barriers, Microaggressions, and Treatment Satisfaction. Journal of Gay & Lesbian Mental Health. 2024 March 6. doi: https://doi.org/10.1080/19359705.2024.2315976

Bane S, Obedin-Maliver J, Ragosta S, Hastings G, Lunn MR, Flentje A, Capriotti MR, Lubensky ME, Tordoff DM, Moseson H. Pathways to Parenthood Among Transgender Men and Gender Diverse People Assigned Female or Intersex at Birth in the United States: Analysis of a Cross-Sectional 2019 Survey. AJOG Global Reports. 2024 August 20. 4(3): 1-14. doi: https://doi.org/10.1016/j.xagr.2024.100381.

Clark KD, Lunn MR, Bosse JD, Sevelius JM, Dawson-Rose C, Weiss SJ, Lubensky ME, Obedin-Maliver J, & Flentje A. Societal stigma and mistreatment in healthcare among gender minority people: a cross-sectional study. Int J Equity Health. 2023 Aug, 24; 22(1):162. doi: https://doi.org/10.1186/s12939-023-01975-7

Clark, K.D., Luong, S., Lunn, M.R., Flowers, E., Bahalkeh, E., Lubensky, M.E., et al. Healthcare Mistreatment, State-Level Policy Protections, and Healthcare Avoidance Among Gender Minority People. Sex Res Social Policy. 2022. Epub 2022, July 15. doi: 10.1007/s13178-022-00748-1

Compte EJ, Cattle CJ, Lavender JM, Murray SB, Brown TA, Capriotti MR, Flentje A, Lubensky M, Obedin-Maliver J, Lunn MR, Nagata JM. 2021. Psychometric evaluation of the Muscle Dysmorphic Disorder Inventory (MDDI) among cisgender gay men and cisgender lesbian women. Body Image. https://doi.org/10.1016/j.bodyim.2021.04.008

Flentje, A., Clark, K.D., Cicero, E., Capriotti, M. R., Lubensky, M.E., Sauceda, J., Neilands, T. B., Lunn, M. R., Obedin-Maliver, J. (In press). Minority stress, structural stigma, and physical health among sexual and gender minority individuals: Examining the relative strength of the relationships. Annals of Behavioral Medicine. https://doi.org/10.1093/abm/kaab051

Grindlay K, Obedin-Maliver J, Ragosta S, Hastings J, Lunn MR, Flentje A, Capriotti MR, Dastur Z, Lubensky ME, Moseson H. Interest in over-the-counter progestin-only pills among transgender, nonbinary, and gender-expansive individuals in the United States. Am J Obstet Gynecol. 2024 Feb 14; S0002-9378(24) 00076-0. doi: https://doi.org/10.1016/j.ajog.2024.02.006.

Inman EM, Obedin-Maliver J, Ragosta S, Hastings J, Berry J, Lunn MR, Flentje A, Capriotti MR, Lubensky ME, Stoeffler A, Dastur Z, Moseson H. Reports of negative interactions with healthcare providers among transgender, nonbinary, and gender-expansive people assigned female at birth in the United States: results from an online, cross-sectional survey. Int J Environ Res Public Health. 2023 May, 31; 20 6007. doi: https://doi.org/10.3390/ijerph20116007

Lamba S, Obedin-Maliver J, Mayo J, Flentje A, Lubensky ME, Dastur Z, Lunn MR. Self-Reported Barriers to Care among Sexual and Gender Minority People with Disabilities: Findings from The PRIDE Study. AJPH. 2023 July, 20: e1-e10. https://ajph.aphapublications.org/doi/epdf/10.2105/AJPH.2023.307333 (doi: https://doi.org/10.2105/AJPH.2023.307333)

Lambrou NH, Gleason CE, Obedin-Maliver J, Lunn MR, Flentje A, Lubensky ME, Flatt JD. Subjective Cognitive Decline Associated with Discrimination in Medical Settings among Transgender and Nonbinary Older Adults. Int. J. Environ. Res. Public Health. 2022, July 27; 19(15). doi: https://doi.org/10.3390/ijerph19159168

Moseson H, Fix L, Hastings J, Stoeffler A, Lunn MR, Flentje A, Lubensky ME, Capriotti MR, Ragosta R, Forsberg H, Obedin-Maliver J. (2020) Pregnancy intentions and outcomes among transgender, nonbinary, and gender-expansive people assigned female or intersex at birth in the United States: results from a national, quantitative survey. IJTH Special Issue: Trans Pregnancy: Fertility, reproduction and body autonomy. https://doi.org/10.1080/26895269.2020.1841058.

Nagata JM, Compte EJ, McGuire FH, Lavender JM, Brown TA, Capriotti MR, Fletje A, Lubensky ME, Obedin-Maliver J, Lunn MR. Factor structure and psychometric properties of the Muscle Dysmorphic Disorder Inventory (MDDI) among transgender women. Body Image. 2024 December. Epub ahead of print. doi: https://doi.org/10.1016/j.bodyim.2024.101798.

Nagata JM, McGuire FH, Lavender JM, Brown TA, Murray SB, Compte EJ, Cattle CJ, Flentje A, Lubensky ME, Obedin-Maliver J, Lunn MR. Appearance and performance-enhancing drugs and supplements (APEDS): Lifetime use and associations with eating disorder and muscle dysmorphia symptoms among cisgender sexual minority people. Eating Behaviors, 2022, 101595, ISSN 1471-0153, https://doi.org/10.1016/j.eatbeh.2022.101595.

Pho A.T., Bates N., Snow A., Zhang A., Logan R., Dastur Z., Lubensky M.E., Flentje A., Lunn M.R. & Obedin-Maliver J. Asking sexual orientation and gender identity on health surveys: Findings from cognitive interviews in the United States across sexual orientations and genders. SSM – Qualitative Research in Health. 2023 September 29; doi: doi.org/10.1016/j.ssmqr.2023.100344.

Ragosta S, Obedin-Maliver J, Fix L, Stoeffler A, Hastings J, Capriotti MR, Flentje A, Lubensky ME, Lunn MR, Moseson H (2021) From ‘shark-week’ to ‘mangina’: an analysis of words used by people of marginalized sexual orientations and/or gender identities to replace common sexual and reproductive health terms, Health Equity 5:1, 1–11, DOI: doi.org/10.1089/heq.2021.0022

Rosendale N, Guterman EL, Obedin-Maliver J, Flentje A, Capriotti MR, Lubensky ME, Lunn MR. Migraine, migraine disability, trauma, and discrimination in sexual and gender minority individuals. Neurology Jul 2022, 10.1212/WNL.0000000000200941. https://doi.org/10.1212/WNL.0000000000200941.

Schwartz BL, Tran NK, Mayo J, Peitzmeier SM, Poteat TC, Lubensky ME, Flentje A, Obedin-Maliver J, Lunn MR. Side Effect Profiles of Non-Hormonal, Non-Surgical Gender-Affirming Body Modifications. LGBT Health. 2025 May 28. Epub ahead of print. doi: https://doi.org/10.1089/lgbt.2024.0319.

Tebbe EA, Lisha N, Neilands T, Lubensky ME, Dastur Z, Lunn M, Obedin-Maliver J, Flentje A. Understanding differences in types of social support and their effects on mental health over time for trans and nonbinary adults. Psychol Sex Orientat Gend Divers. 2025 Jan 2. Epub ahead of print. doi: https://doi.org/10.1037/sgd0000789.

Tordoff DM, Lunn MR, Chen B, Flentje A, Dastur Z, Lubensky ME, Capriotti M, Obedin-Maliver J. Testosterone Use and Sexual Function among Transgender Men and Gender Diverse People Assigned Female at Birth. American Journal of Obstetrics & Gynecology. 2023 September 9; doi: https://doi.org/10.1016/j.ajog.2023.08.035

Tran NK, Lett E, Cassese B, Streed Jr CG, Kinitz DJ, Dastur Z, Lubensky ME, Flentje A, Obedin-Maliver J, Lunn MR. Conversion practice recall and mental health symptoms in sexual and gender minority adults in the USA: a cross-sectional study. The Lancet Psychiatry. 2024 September 30. Epub ahead of print. doi: https://doi.org/10.1016/S2215-0366(24)00251-7.

Tran NK, Lett E, Flentje A, Ingram S, Lubensky ME, Dastur Z, Obedin-Maliver J, Lunn MR. Inequities in Conversion Practice Exposure at the Intersection of Ethnoracial and Gender Identities. Am J Public Health. 2024, March 13; 114 (4): 424-434. doi: https://doi.org/10.2105/AJPH.2024.307580

For activity related questions, please contact
     Visit: https://med.stanford.edu/edtech/contact.html  

For CME general questions, please contact 
     Email: [email protected]

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

There are no relevant financial relationships with ACCME-defined ineligible companies for anyone who was in control of the content of this activity, except those listed in the table below. All of the relevant financial relationships listed for these individuals have been mitigated.